NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization15.13 mln
Float5.96 mln
Earnings Date05/18/2026
EPS
0.82
Decent
P / E
1.84
Deeply undervalued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
2509
Highly suspicious
1-Year Forecast
5.50
Transformational upside
Relative Strength
90
/ 100
Top performer
Business Description
Traws Pharma Inc. is a clinical-stage pharmaceutical company based in Newtown, Pennsylvania, focused on developing oral pill-based treatments for viral respiratory illnesses and cancer. Its pipeline includes drugs targeting COVID-19, seasonal flu, and bird flu, as well as cancer treatments being studied in both solid tumors and blood cancers. The company works with several licensing partners and draws on research collaborations to advance its programs. Formerly known as Onconova Therapeutics, the company adopted its current name in April 2024 and has been operating since 1998.
